Sanofi Specialty Care aims to push the boundaries of science, deliver innovative solutions, and add value to patients and the healthcare system. See how we’re attempting to address clinical and economic burdens of disease in immunology, neurology, oncology, rare blood disorders, and rare diseases.
 

Our medicines are designed to improve clinical outcomes and deliver value to patients, providers, and payers.

From our work in type 2 inflammation to our pipeline of exploratory therapies, we’re working hard to advance the science of immunology.

Our ambition in oncology is to develop potential first-in-class medicines to combat difficult-to-treat cancers.

We’re investigating potential treatments to slow or even halt neurodegeneration in diseases, such as multiple sclerosis.

Sanofi is going all in on artificial intelligence (AI) to help accelerate drug discovery, enhance clinical trial design, and improve the manufacturing and supply of medicines and vaccines.

Take a closer look at the various vaccines in our portfolio that aim to prevent costly and potentially debilitating illnesses.

The annual healthcare costs for members with chronic obstructive pulmonary disease (COPD) with acute exacerbations are 10-fold higher than for members without COPD exacerbations.